Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MORE
Intellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Blog articles 17.12.20
Drug shortages: Lessons from the COVID-19 crisis
Everything you always wanted to know about drug shortages (but were afraid to ask)
Read Article -
Blog articles 16.12.20
Alzheimer’s treatments in development could launch a new era in dementia care (Guest blog)
With new therapies on the horizon, we may be at a turning point. Patients, experts and industry agree that now is the time to prepare for a better future...
Read Article -
Statements & press releases 15.12.20
EFPIA Response to the European Commission's Roadmap on a Green Paper on Ageing
EFPIA welcomes the European Commission’s work on a Green Paper on Ageing aiming at fostering solutions to one of Europe’s most pressing issues: demographic...
Read Article -
External Events 04.02.21
9th ACCELERATE Paediatric Oncology Conference
REGISTRATION IS NOW OPEN with specially reduced rates available before the early rate deadline of 4 January 2021.
View Event -
External Events 25.02.21
2nd ICPerMed conference on Personalised Medicine - From Vision to Practice
New dates announced
View Event -
External Events 04.03.21
Value Based Healthcare Conference – Tallinn 2021
The conference aims at raising awareness and knowledge among the healthcare community on the value of patient-centered healthcare.
View Event
Featured Articles
